Statistics

Total Visits

Views
cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients60

Select a period of time:

Number of views in the range

Views
cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients29

Views

Views
June 20250
July 202512
August 20251
September 20256
October 20252
November 20257
December 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil10
United States8
United Kingdom3
Argentina3
Canada1
Germany1
Jamaica1
Peru1
South Africa1
 

Top cities views

Views
Dallas6
São Paulo2
Araguaína1
Belleville1
Brasília1
Buenos Aires1
Comas1
Ezeiza1
Hamburg1
Itabaianinha1